MiRNA profiling studies of CLL
| MiRNA signatures . | Prognostic marker . | Study . | Year . |
|---|---|---|---|
| miR-15a, miR-195, miR-221, miR-23b, miR-155, miR-223, miR-29a-2, miR-24-1, miR-29b-2, miR-146, miR-16-1, miR-16-2, and miR-29c | Unmutated IgVH, high ZAP-70 | Calin et al21 | 2005 |
| miR-29c and miR-223 | Unmutated IgVH | Fulci et al80 | 2007 |
| miR-181a, let-7a, miR-30d, miR-155, and miR-29 | Unmutated IgVH | Marton et al60 | 2008 |
| miR-223 and miR-29c | ZAP-70 and LPL | Stamatopoulos et al81 | 2009 |
| MiRNA signatures . | Prognostic marker . | Study . | Year . |
|---|---|---|---|
| miR-15a, miR-195, miR-221, miR-23b, miR-155, miR-223, miR-29a-2, miR-24-1, miR-29b-2, miR-146, miR-16-1, miR-16-2, and miR-29c | Unmutated IgVH, high ZAP-70 | Calin et al21 | 2005 |
| miR-29c and miR-223 | Unmutated IgVH | Fulci et al80 | 2007 |
| miR-181a, let-7a, miR-30d, miR-155, and miR-29 | Unmutated IgVH | Marton et al60 | 2008 |
| miR-223 and miR-29c | ZAP-70 and LPL | Stamatopoulos et al81 | 2009 |
LPL indicates lipoprotein lipase.